|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0395 AUD | +3.95% |
|
+1.28% | -46.62% |
| 05-08 | Radiopharm Theranostics to be Featured in Healthcare Events Hosted by B. Riley Securities | MT |
| 02-29 | Radiopharm Theranostics Doses First Patient in Pancreatic Cancer Imaging Study | MT |
Radiopharm Theranostics Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported sales was AUD 0.292359 million. Net loss was AUD 12.55 million compared to AUD 17.39 million a year ago.
Basic loss per share from continuing operations was AUD 0.0454 compared to AUD 0.16 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -46.62% | 11.47M | |
| +35.01% | 709B | |
| +27.22% | 595B | |
| -2.60% | 367B | |
| +20.83% | 334B | |
| +5.69% | 289B | |
| +14.85% | 239B | |
| +9.45% | 211B | |
| -3.84% | 203B | |
| +10.77% | 171B |
RADIOPHARM THERANOSTICS LIMITED 